Monopar Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Monopar Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.7k | 2.6k | 0.68 |
2023-12-31 | $4.0k | 12k | 0.34 |
2023-09-30 | $45 | 72 | 0.63 |
2023-03-31 | $8.9k | 6.4k | 1.39 |
2022-12-31 | $7.5k | 3.2k | 2.37 |
2022-09-30 | $8.0k | 5.4k | 1.48 |
2022-06-30 | $45k | 20k | 2.30 |
2022-03-31 | $8.0k | 3.1k | 2.58 |
2021-12-31 | $10k | 3.1k | 3.26 |
2021-03-31 | $4.0k | 571 | 7.01 |
2020-12-31 | $6.0k | 952 | 6.30 |
2020-03-31 | $0 | 15 | 0.00 |
2019-12-31 | $21k | 1.3k | 16.28 |